Vanda Pharmaceuticals Inc.

BARCLAYS PLC VNDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

191,036

Value ($000)

1,685

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,685	0.0%	191,036	12/31/2025
2025 Q3	3/31/2026	1,111	0.0%	222,579	9/30/2025
2025 Q2	2/27/2026	1,059	0.0%	224,404	6/30/2025
2025 Q1	3/17/2026	772	0.0%	168,093	3/31/2025
2024 Q4	3/19/2026	854	0.0%	178,368	12/31/2024
2024 Q3	3/31/2026	724	0.0%	154,297	9/30/2024
2024 Q2	3/23/2026	382	0.0%	67,620	6/30/2024
2024 Q1	3/24/2026	517	0.0%	125,676	3/31/2024
2023 Q4	3/25/2026	724	0.0%	171,638	12/31/2023
2023 Q3	3/26/2026	554	0.0%	128,330	9/30/2023
2023 Q2	3/30/2026	824	0.0%	125,065	6/30/2023
2023 Q1	3/30/2026	681	0.0%	100,294	3/31/2023
2022 Q4	3/30/2026	715	0.0%	96,744	12/31/2022
2022 Q3	11/3/2022	981	0.0%	99,302	9/30/2022
2022 Q2	8/12/2022	199	0.0%	18,258	6/30/2022
2022 Q1	5/16/2022	507	0.0%	44,769	3/31/2022
2021 Q4	2/14/2022	1,124	0.0%	71,641	12/31/2021
2021 Q3	11/9/2021	974	0.0%	56,802	9/30/2021
2021 Q2	8/13/2021	729	0.0%	33,890	6/30/2021
2021 Q1	5/13/2021	1,467	0.0%	97,698	3/31/2021
2020 Q4	2/11/2021	1,083	0.0%	82,389	12/31/2020
2020 Q3	11/12/2020	1,035	0.0%	107,309	9/30/2020
2020 Q2	8/12/2020	1,109	0.0%	97,039	6/30/2020
2020 Q1	5/13/2020	760	0.0%	73,349	3/31/2020
2019 Q4	2/10/2020	1,473	0.0%	89,791	12/31/2019
2014 Q1	5/15/2014	461	0.0%	28,769	3/31/2014
2013 Q4	2/13/2014	3,939	0.0%	328,338	12/31/2013